CIK 0000070487 · Accelerated filer
NRC HEALTH
Sign in to watch- Ticker
- NRC
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470634000
- Phone
- 4024752525
- Business address
- 1245 Q STREET, LINCOLN, NE, 68508
- Former names
- NATIONAL RESEARCH CORP
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Executive or director change · Bylaws or fiscal year change
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Executive Vice President acquired 60,000 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 4 Open-market buy EVP & Chief Financial Officer bought 8,000 shares at $12.27 ($98,162)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B7 Offering Prospectus
- 8-K Event Results of operations
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 21,271 shares (to pay taxes)
- 4 Grant or award EVP, Strategic Insights acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chairman acquired 9,145 shares (option exercise)
Page 2 of 66 · 1,307 filings